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Abstract
Background
Haemoglobin variants, Sickle (HbS) and foetal (HbF) have been associated with malaria
protection. This study explores epistatic interactions between HbS and HbF on
malaria infection.
Methods
The study was conducted between March 2004 and December 2013 within the sickle cell
disease (SCD) programme at Muhimbili National Hospital, Tanzania. SCD status was cate-
gorized into HbAA, HbAS and HbSS using hemoglobin electrophoresis and High Perfor-
mance Liquid Chromatography (HPLC). HbF levels were determined by HPLC. Malaria was
diagnosed using rapid diagnostic test and/or blood film. Logistic regression and generalized
estimating equations models were used to evaluate associations between SCD status, HbF
and malaria.
Findings
2,049 individuals with age range 0-70 years, HbAA 311(15.2%), HbAS 241(11.8%) and
HbSS 1,497(73.1%) were analysed. At enrolment, malaria prevalence was significantly
higher in HbAA 13.2% compared to HbAS 1.24% and HbSS 1.34% (p<0.001). Mean HbF
was lower in those with malaria compared to those without malaria in HbAA (0.43% vs
0.82%) but was the reverse in HbSS (8.10% vs 5.59%). An increase in HbF was associated
with a decrease in risk of malaria OR=0.50 (95%CI: 0.28, 0.90; p=0.021) in HbAA, whereas
for HbSS the risk of malaria increased OR=2.94 (1.44, 5.98; p=0.003). A similar pattern was
seen during multiple visits; HbAA OR=0.52 (0.34, 0.80; p=0.003) vs HbSS OR=2.01 (1.27,
3.23; p=0.003).
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Conclusion
Higher prevalence of malaria in HbAA compared to HbAS and HbSS confirmed the protec-
tive effect of HbS. Lower prevalence of malaria in HbAA with high HbF supports a protective
effect of HbF. However, in HbSS, the higher prevalence of malaria with high levels of HbF
suggests loss of malaria protection. This is the first epidemiological study to suggest a nega-
tive epistasis between HbF and HbS on malaria.
Background
Sickle (HbS) and fetal hemoglobin (HbF) are hemoglobin variants that confer immunity against
malaria [1–4]. HbS is a pathological haemoglobin variant resulting from the mutation on the β-
globin gene on chromosome 11. It is inherited in Mendelian manner, with protection against
malaria in both the heterozygous state HbAS [1,2] and the homozygous state HbSS [3]. HbF is
a normal haemoglobin variant which is the predominant hemoglobin during the fetal period.
The level of HbF is 100% at birth, but decreases in the first five years of life to reach a level of
less than 2% in normal (HbAA) individuals [5]. In individuals with HbSS, the level of HbF is
variable but may reach 20%, with high levels of HbF associated with amelioration of disease se-
verity [7]. Although the relationship between HbF and malaria has been less well described,
HbF is also associated with reduced risk of malaria [4,8]. The malaria hypothesis proposes that
areas with high malaria transmission will have a high prevalence of malaria-protective haemo-
globin variants [9]. However, epistatic interaction between genes has been described with ma-
laria-protective genes, when the presence of one gene influences the phenotypic expression of
another gene. Negative epistasis has been reported between sickle hemoglobin and α-thalassae-
mia, where their co-existence results in the loss of the malaria protection effect of either Hb var-
iant [10]. In this study, we set out to explore the epistatic interaction between HbS and HbF on
malaria in Tanzania, a country with a high prevalence of malaria and SCD.
Material and Methods
Study area
The study was conducted at Muhimbili National Hospital (MNH), in Dar-es-Salaam, Tanza-
nia. This is the largest and most densely populated region in Tanzania (population is 4.4 mil-
lion; Population density of 3,133 persons per square km) [11]. The prevalence of malaria in
children below five years in Dar-es-Salaam is 3.6% [12]. The birth prevalence of SCD in Tanza-
nia is 6 per 1,000 live births, ranking Tanzania as the fourth country in the world (after Nigeria,
Democratic Republic of Congo (DRC) and India) with the highest number of SCD births [13].
Study population
The study included individuals seen at MNH between March 2004 and December 2013 within
the framework of the Muhimbili Sickle Cell (MSC) programme which has been previously de-
scribed [3,14]. Briefly, individuals are identified at paediatric SCD or haematology clinics or
during hospitalization and are screened for SCD. Screening is done either due to clinical fea-
tures suggestive of SCD, referral by a doctor or self-referral by individuals. Individuals found to
have HbAA or HbAS receive counseling regarding their SCD status and are not required to re-
turn to the clinic. Some of these individuals may have more than one visit due to non-confir-
mation of SCD diagnosis at initial visit. Individuals with HbSS are enrolled into the MSC
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clinic, where detailed clinical and laboratory information are collected. Appointments for fol-
low up visits are scheduled every 3–9 months. Care is provided to individuals with HbSS fol-
lowing national and hospital treatment guidelines. This includes folic acid, health education
and malaria prevention using insecticide treated nets and prompt malaria case management.
No chemoprophylaxis against malaria is provided as a preventive measure.
Laboratory methods
SCD diagnosis (HbAA, HbAS and HbSS status) was done by alkaline hemoglobin electropho-
resis (Helena, Sunderland, Tyne &Wear, UK). Confirmation of sickle phenotype and quantifi-
cation of HbF was done by high performance liquid chromatography (HPLC) (Variant I
analyzer, Bio-Rad, Hercules, CA, USA). For HbSS individuals younger than five years at enrol-
ment into the MSC, HPLC was repeated after 5 years of age. This is because the level of HbF
within an individual does not significantly change after the age of five [5]. Malaria screening
was done at enrolment, during the clinic or at hospitalisation for patients with clinical features
suggestive of malaria (fever or history of fever, general body pain, vomiting, and anaemia). Ma-
laria diagnosis was done using rapid diagnostic test (RDT) (Parahit, Span Diagnostics; or Para-
check, Orchid Biomedical Systems) and/or blood slide (BS) using Giemsa stain.
Ethical approval
The study was approved by the ethical committee of the Muhimbili University of Health and
Allied Sciences (reference MU/RP/AEC/VOL XI/33). Written informed consent, in the local
language (Kiswahili), was obtained from parents or guardians of children and from patients
who were above 18-years old.
Statistical methods
Information was checked for consistency before double entry into a database written in
MySQLv5.0 (Sun Microsystems Inc, Santa Clara, California, USA). STATA 11 (Stata Corp,
College Station, TX) and R 30.03 (http://www.R-project.org/) were used for analysis. The SCD
status was categorized into three phenotypes: HbAA, HBAS and HbSS. Malaria infection was
defined as any positive diagnosis determined by a positive blood slide using microscopy or by
an RDT. This was irrespective of clinical features suggestive of malaria (fever or history of
fever, general body pain, vomiting, and anaemia). The level of HbF was handled as a continu-
ous variable. The MSC study is a cohort study and consists of longitudinal follow-up of individ-
uals with HbSS. Therefore, HbSS have repeated clinic visits, and hospitalisations, with repeated
measurements for malaria within individuals. The long period of follow-up and multiple visits
of the MSC allowed evaluation of malaria, which has a low prevalence in HbSS and after the
age of 5 years. Evaluation of the relationship between HbF, SCD status and malaria was done
using the baseline visit as the date of HbF measurement as well as testing for malaria. Since the
level of HbF is known to decrease in the first 5 years of life and the prevalence of malaria de-
creases with age, we also evaluated the association limiting analysis to measurements done in
individuals above 5 years.
Continuous variables (age and HbF) variables were transformed toward normality using a
square root transformation. Malaria prevalence was defined as the total number of positive
tests over total number of tests. The proportions of malaria by SCD status were compared
using a χ2-test or Fisher exact test if the expected count in one of the cells was less than five.
HbF levels were compared using a t-test or Wilcoxon rank sum test in small samples. Logistic
regression and Generalised Estimating Equation (GEE) models were used to assess the risks of
malaria infection controlling for age and sex in single and repeated observations recorded
Effect of Sickle and Foetal Haemoglobin on Malaria
PLOS ONE | DOI:10.1371/journal.pone.0125929 May 12, 2015 3 / 10
during visits, respectively, to account for age dependent effects such as body immunity against
malaria and HbF levels [5,6]. Models with and without interaction between SCD status and
HbF fitted in logistic regression were compared using log likelihood ratio tests. A variable was
considered statistically significant if its p-value was< 0.05.
Results
2,049 individuals with age range 0–70 years, HbAA 311(15.2%), HbAS 241(11.8%) and HbSS
1,497(73.1%) with HbF and HbS data were screened for malaria (Fig 1).
General characteristics of the study population are presented in Table 1. The prevalence of
malaria at baseline was 3.12%, with higher prevalence in children under-five years of age and
decreasing prevalence with increasing age (χ2trend = 9.8, p = 0.002). Individuals in the HbAA
(13.18%) group had a significantly higher prevalence of malaria than HbAS (1.24%) or HbSS
(1.34%) (χ(2)
2 = 122.6, p<0.001).
Fig 1. Participants in the malaria study in the Sickle Cell Disease programme at Muhimbili National Hospital.
doi:10.1371/journal.pone.0125929.g001
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There were 14,022 visits with information on malaria, HbF and SCD. The proportion of vis-
its contributed by each SCD group was HbAA = 355 (2.5%), HbAS = 382 (2.7%) and
HbSS = 13,285(94.7%). The prevalence of malaria for all visits was 1.36%, and when catego-
rized by SCD status was HbAA 12.1%, HbAS 1.3% and HbSS 1.1%, (Fig 1). Analysis in individ-
uals aged5 as shown in S1 Fig and Table 1, shows that although malaria infection was lower
in this age group, the results were consistent by SCD status as well as by HbF levels when com-
pared to that of the population composed of all ages.
Malaria in HbAA, HbAS and HbSS and level of HbF
Individuals with malaria had significantly lower HbF compared to those with no malaria 1.89%
vs 4.22% (p<0.001). Mean HbF in individuals with malaria in the HbAA group was 0.43%
(95%CI: 0.27, 063) compared to 0.82% (0.65, 1.01) in the no malaria group (p = 0.05). For the
HbAS group, the mean HbF in the two groups were not significantly different (p = 0.983).
However, for the HbSS group, the mean HbF was higher in the malaria group 8.10% (5.84,
10.71) compared to the no malaria group 5.59% (5.36, 5.82), p = 0.025, Table 1 and Fig 2A.
When analysis was done for individuals aged5 years, an age above which HbF is stable, a
similar pattern of lower HbF in HbAA and high HbF in the HbAS and HbSS individuals with
malaria infection was seen, Table 1, Fig 2B and S1 Table. However, the level of significance in
HbAA was reduced due to small sample size of individuals with malaria.
Analysis of the effect of HbF and HbS on malaria was evaluated at baseline and during mul-
tiple visits (Table 2). A logistic model with an interaction term (SCD status and HbF) as pre-
sented in Table 2, was significant (Deviance = 9.64 with 2 degrees of freedom, p = 0.008) from
Table 1. Characteristics of the study participants at baseline visit.
Sample size Malaria status Test statistic
Negative Positive (P-value)*
Population size (%) 2,049 1985 (96.9) 64(312)
Age group: 0–4y 612 582 (95.1) 30 (49) χ2trend = 98 (0002)
5–14y 955 930 (97.38) 25 (262)
15y+ 475 467 (98.32) 8 (168)
Missing 7 6 (85.71) 1(1429)
Sex Males 1,032 997(96.61) 35(339) χ2 = 0493 (0482)
Females 1,017 988(97.15) 29 (285)
SCD status HbAA 311 270 (86.82) 41 (1318) χ2(2) = 1226 (<0001)
HbAS 241 238 (98.76) 3 (124)
HbSS 1,497 1477(98.66) 20(134)
HbF (mean, 95%CI)
Overall 2,049 4.22 (4.02, 4.42) 1.89 (1.16, 2.79) t = 4.84 (<0.001)
HbAA 311 0.82 (0.65,1.01) 0.43 (0.27, 0.63) t = 1.94 (0.053)
HbAS 241 2.04 (1.64, 2.48) 1.79 (0.36, 10.75) z = 0.021 (0.983)
HbSS 1,497 5.59 (5.36,5.82) 8.10 (5.84, 10.71) t = -2.250 (0.025)
HbF (5years) (mean, 95%CI)
Overall 1,430 3.74 (3.54, 3.94) 2.78 (1.39, 4.65) t = 1.48 (0.138)
HbAA 151 0.47 (0.33, 0.64) 0.18 (0.04, 0.41) t = 1.48 (0.140)
HbAS 127 1.13 (0.74, 1.60) 3.19 (0.13, 10.30) z = -1.50 (0.135)
HbSS 1152 4.74 (4.53, 4.96) 7.94 (5.29, 11.13) t = -2.98 (0.003)
*All test statistics excludes missing values
doi:10.1371/journal.pone.0125929.t001
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the model with no interaction. Results from the interaction model indicate that in the HbAA
group, an increase in HbF is associated with a decreased risk of malaria OR = 0.50 (95%CI:
0.28,0.90; p = 0.021), whereas for HbSS group, the risk of malaria increased with increase in
HbF, OR = 2.94 (1.44, 5.98; p = 0.003).
A similar pattern, with a stronger effect was seen when the model was fitted to data obtained
from multiple visits, using GEE to take into account clustering within individuals (Table 2).
Fig 2. Association betweenmalaria (Blank = Negative, Filled = Positive) by SCD and Foetal hemoglobin levels for individuals in all ages (A) and for
5 years (B). Sample size of each group is shown on the x-axis and p-values (p) in the graph were derived from t-tests (HbAA and HbSS) andWilcox sign
rank test (HbAS). The box showmedian (central line) and inter quartile range (IQR). The top whisker corresponds to the largest observation that is less than
or equal to the 75th percentile + 1.5 x IQR. The bottom whisker corresponds to the smallest observation that is greater than or equal to the 25th percentile—
1.5 x IQR, while open circles are the outliers.
doi:10.1371/journal.pone.0125929.g002
Table 2. Coefficient estimates frommultivariate logistic (single visit at the time of HbFmeasurement) and GEE (multiple visits) regression models
of malaria in relation to SCD status, HbF levels and age for individuals of all ages.
Single visit (n = 2,042)* Multiple visits (n = 14,002)**
Variable OR 95% CI P-value OR 95% CI P-value
HbAA 1 1
HbAS 0.07 0.01, 0.52 0.009 0.07 0.02, 0.24 <0.001
HbSS 0.02 0.015, 0.09 <0.001 0.05 0.03, 0.10 <0.001
HbF§ 0.50 0.28, 0.90 0.021 0.52 0.34, 0.80 0.003
HbAS*HbF§ 1.59 0.44, 5.73 0.482 1.77 0.95, 3.32 0.073
HbSS*HbF§ 2.94 1.44, 5.98 0.003 2.01 1.27, 3.23 0.003
Age§ 0.80 0.63, 1.02 0.071 0.81 0.71, 0.91 0.001
§Transformed by square root
*Seven individuals with missing age excluded
**20 visits with missing age excluded
doi:10.1371/journal.pone.0125929.t002
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Lower HbF levels were observed among individuals with malaria in the HbAA group
OR = 0.52 (0.34, 0.80; p = 0.003) whereas in the HbSS group, higher HbF levels were observed
among the individuals with malaria OR = 2.01 (1.27, 3.23; p = 0.003). Similarly results were ob-
tained for individuals aged5 years, with slightly higher odds ratios for the interaction be-
tween HbAS or HbSS and HbF levels, S1 Table.
Discussion
Innate genetic immunity against malaria has been described in hemoglobin variants, particu-
larly HbS and α-thalassemia. This has been the subject of considerable research, as understand-
ing the mechanisms of protection that occur naturally in human could lead to development of
interventions. However, the epistatic effect of various genetic variants and their resultant pro-
teins offers additional insights into mechanisms of biological protection and geographical dis-
tribution on genes and disease. This study was designed to evaluate the effect of co-existence of
HbF and HbS on malaria.
We initially set out to describe the independent association of HbS and HbF with protection
against malaria. For HbS, we confirmed previous observations [1,2] that the prevalence of ma-
laria in individuals with HbAS and HbSS was lower compared to those with HbAA. Less is
known about the protective effect of HbF. Here we showed that a protective effect was evident
in individuals with HbAA, with malaria being more common among those with lower levels of
HbF. This effect had previously been described in newborns, in-vitro and studies in mice
[4,15]. In an in-vitro study, Pasvol et al [4] showed that there were fewer parasites in cells con-
taining HbF and there was a growth retardation of parasites in cells containing HbF. The distri-
bution and growth of Plasmodium falciparum was compared in red blood-cells containing
either adult or fetal haemoglobins. In in-vitro cultures, cord blood-cells were invaded more
readily, but there was a paucity of parasites in cells containing HbF in the blood of infected in-
fants aged 3–6 months. Some of studies have associated retardation of parasite growth in cell
containing HbF with reduced ability of HbF-containing red blood cells to handle the oxidative
stress imposed by developing parasites [16]. However, one of the recent studies associated HbF
with impairment of binding of parasitized red blood cells to human microvascular endothelial
cells, monocytes and nonparasitized erythrocytes [17].
This is one of the first epidemiological studies of this magnitude to suggest the protective effect
of HbF against malaria. Our data suggest that there is negative epistasis between HbF and HbS on
malaria protection. There was a loss of protection against malaria with increasing HbF levels in
the HbSS group. Negative epistasis between HbS and α-thalassaemia has been described in Kenya
[11] and another study has described epistatic variation between α-thalassemia and Haptoglobin
(Hp) [18]. In the latter, individuals with Hp2-1 genotype in combination with heterozygote or ho-
mozygote α-thalassemia were protected from the disease, while those with Hp2-2 were not pro-
tected [18]. The high level of HF in individuals with malaria may also be a result of other factors
such as stress erythropoiesis, drug induction and diseases [19,20]. Further studies on pathophysi-
ology are required to elucidate the mechanism of high HbF inmalaria. The occurrence of negative
epistasis between HbS and HbF in malaria would have implications in our understanding of ma-
laria protective mechanisms in areas with high prevalence of SCD andmalaria. The interaction
between these two haemoglobins and their effect on malaria may differ between populations with
different levels of HbF, for example in Asia population where HbF levels are higher than African
population [21,22]. Epistatic interactions between different malaria-protective haemoglobin vari-
ants may be one of the factors that determines their geographical distribution [22]
This study was undertaken within the epidemiological framework of a cohort study for
HbSS and it had a limited sample size especially for HbAS and HbAA. Thus, this was not a
Effect of Sickle and Foetal Haemoglobin on Malaria
PLOS ONE | DOI:10.1371/journal.pone.0125929 May 12, 2015 7 / 10
random sample of the general population. This may have led to selection bias for those with
malaria in the HbAA and HbAS groups but is unlikely to have biased selection of individuals
with varying levels of HbF. Despite higher levels of HbF among individuals with HbAS infected
with malaria; these were not significantly different from un-infected individuals. This may be
the result of the small sample size and few malaria events in this population. Further studies
should be done to evaluate these observations in population—based studies. Furthermore, ad-
ditional research is needed to evaluate the effect of these haemoglobin variants on malaria para-
site density as well as the quantitative effects between HbS and HbF on malaria. This can be
done by exploring the effect of different levels of HbF and HbS on presence of malaria parasi-
taemia as well as the association with malaria parasite density. Further studies should examine
the effect of HbF, HbS and the wider range of haemoglobin variants on malaria, clinical out-
comes and immune responses to provide a more complete picture of the overall additive and
epistatic contribution of genetic regulation in Africa. The interaction between HbS and HbF
with other hemoglobin disorders like α-thalassemia as well as the mechanism of loss of protec-
tion against malaria infection with co-existence of high levels of HbF and sickle gene needs to
be explored further. This study was not able to explore this relationship because of the low
prevalence of malaria infection. Among 1,247 individuals with α- thalassemia data, none
among the HbAA group and one in HbAS had malaria. Evidence suggests that although the
risk of malaria is lower among individuals with SCD, this group has a higher risk of morbidity
and mortality related to malaria. If indeed, the risk for malaria is much higher in those with
higher levels of HbF, this will bring challenges in management of SCD in malaria-endemic
areas. This is because interventions such as Hydroxyurea which increase HbF levels may inad-
vertently result in increasing the risk of malaria.
This is one of the first epidemiological studies to report on the epistatic interaction be-
tween HbF and HbS on malaria. This study opens up further questions that need to be ex-
plored to increase our understanding of the interactions of hemoglobin variants that occur
in malaria endemic area. Such studies should involve population-based, epidemiological
studies involving adequate numbers of individuals with HbAS, HbAA and HbSS in areas
with high transmission of malaria. Further insight can be elucidated from in-vitro studies
that explore the dynamics of malaria infection including the growth of malaria parasites
under different levels of HbF and HbS.
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